Pharmacogenomics, Theranostics and Personalized Medicine-the complexities of clinical trials: challenges in the developing world
… and 23% in the case of patients with diabetes in phase II trials. The failure rate went up to … of a huge and a genetically diverse Indian population, each segment would still represent a …..... Read More